Clinical Trials Browser

OTHER × Anti-Bacterial Agents × 1 year × Clear all

NCT03631173 2026-04-28

MINIMUM

Phase NA Active not recruiting

Gastrointestinal

Biliary Tract Neoplasms, Duodenal Neoplasms, Pancreatic Fistula, Pancreatic Neoplasms

NCT04722978 2025-12-17

Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer

Phase 3 Recruiting

Triple Negative Breast Neoplasms